Epidemiological, clinical and therapeutical aspects of benign prostate hyperplasia at the Laquintinie Hospital of Douala

Abstract

Introduction: Benign prostatic hyperplasia (BPH) is a non-malignant enlargement of the prostate and a common cause of lower urinary tract symptoms in ageing men. The aim of our research was to study the epidemiological, clinical, and therapeutic aspects of BPH at Laquintinie Hospital in Douala.

Methods: A retrospective cross-sectional study was conducted from January 1, 2016, to December 31, 2022. Medical records of patients diagnosed with BPH were included. Sociodemographic, clinical, and therapeutic data were collected and analysed.

Results: BPH accounted for 20.43% of urological diseases. The mean age was 60.41 ± 12.17 years. Acute urinary retention (38.1%) and dysuria (17.2%) were the main presenting complaints. Escherichia coli was the most frequently isolated pathogen (59.7%). Medical treatment was the most common management (66.7%). Among surgical procedures, transvesical adenomectomy was the most frequently performed (67.6%). The main postoperative complication was bleeding.

Conclusion: BPH is common after the age of 40 years, and transvesical adenomectomy remains the main surgical treatment in our setting.